Search Results - "Esfahani, Shiva Hadi"
-
1
Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications
Published in The Journal of pharmacology and experimental therapeutics (01-11-2022)“…Antiprotozoal veterinary drug diminazene aceturate (DIZE) has been proposed to be an angiotensin-converting enzyme 2 (ACE2) activator. Since then, DIZE was…”
Get full text
Journal Article -
2
Challenges with the proposed ACE2 activation mechanism of diminazene aceturate
Published in Clinical and experimental pharmacology & physiology (01-05-2022)Get full text
Journal Article -
3
Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability
Published in ACS medicinal chemistry letters (11-04-2024)“…The peptidase neurolysin (Nln) has been validated as a potential target for developing therapeutics for ischemic stroke (IS). Overexpression of Nln in a mouse…”
Get full text
Journal Article -
4
Correction to “Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability”
Published in Journal of medicinal chemistry (13-01-2022)Get full text
Journal Article -
5
Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals
Published in Pharmaceutical research (01-11-2023)“…Purpose There is growing interest in seeking pharmacological activation of neurolysin (Nln) for stroke treatment. Discovery of central nervous system drugs…”
Get full text
Journal Article -
6
In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals
Published in Pharmaceutical research (01-07-2022)“…Purpose Neurolysin (Nln) is a peptidase that functions to preserve the brain following ischemic stroke by hydrolyzing various neuropeptides. Nln activation has…”
Get full text
Journal Article -
7
Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability
Published in Journal of medicinal chemistry (09-09-2021)“…Peptidase neurolysin (Nln) is an enzyme that functions to cleave various neuropeptides. Upregulation of Nln after stroke has identified the enzyme as a…”
Get full text
Journal Article -
8
Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy
Published in Expert opinion on therapeutic targets (04-05-2022)Get more information
Journal Article -
9
Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators
Published in Bioorganic & medicinal chemistry letters (15-05-2022)“…[Display omitted] Modulating peptidase neurolysin (Nln) has been identified as a potential cerebroprotective target for the development of therapeutics for…”
Get full text
Journal Article -
10
Identification and Characterization of Two Structurally Related Dipeptides that Enhance Catalytic Efficiency of Neurolysin
Published in The Journal of pharmacology and experimental therapeutics (01-11-2021)“…Neurolysin (Nln) is a recently recognized endogenous mechanism functioning to preserve the brain from ischemic injury. To further understand the…”
Get full text
Journal Article